Christopher Bjork

Christopher Bjork practices at Adventist HealthCare Fort Washington Medical Center in Fort Washington, Maryland, part of Columbia Union Conference.

Christopher Bjork's NPI, 1467836346, was assigned on July 10, 2015. Christopher Bjork holds Maryland license D0085429.

Christopher Bjork's primary practice is Adventist HealthCare Fort Washington Medical Center, at 11711 Livingston Road, Fort Washington, MD 20744 in Prince Georges County. The practice phone is (301) 292-7000.

Christopher Bjork's primary practice is Adventist HealthCare Fort Washington Medical Center in Fort Washington, Maryland, part of Columbia Union Conference. Christopher Bjork is also affiliated with Meritus Medical Center. The medical group on file is US Acute Care Solutions (USACS). Dmand AI also links Christopher Bjork to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Bjork practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Christopher Bjork's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Christopher Bjork is licensed in Maryland.

CMS data shows 551 Medicare services from Christopher Bjork across 5 procedure codes in 2024, for 371 Medicare patients. Medicare paid $55,844 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 371 Medicare patients who saw Christopher Bjork in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Bjork's median patient age at 48, with 58% women.

In 2024, Christopher Bjork wrote 211 Medicare Part D claims for 136 patients. 92% of them were for generic drugs. CMS names the drug for 113 of them, across 6 drugs with 11 or more claims each, at $503 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.